Atrium Therapeutics, Inc.
NASDAQ:RNABiotechnology
+$0.16 today
- Market cap
- $143.23M
- Beta
- 0.42
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$3.78
Volume 0.22M
Average 0.35M
RNA Other Non-Cash Items
Other non-cash adjustments that reconcile net income to operating cash flow.
Atrium Therapeutics, Inc.NASDAQ: RNA
Other Non-Cash Items · Q1 FY2026 · quarter ended Mar 2026
Other non-cash items of $13.05M in Q1 FY2026
Q1 FY2026 other non-cash items was $13.05M.
Context
- Other non-cash items amounted to 3.8% of revenue in FY2025.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Non-Cash Items history
USD · from the cash flow
- Latest · FY2025
- 712K USD
- Year-over-year change
- —
| Period | Period end | Other Non-Cash Items | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 712K | — |
Other Non-Cash Items vs competitors
How RNA compares with its peers on the latest reported figures
No competitor Other Non-Cash Items figures are available to compare.
Cash Flow Statement
Atrium Therapeutics, Inc.
NASDAQ:RNA
Intrinsic Alpha fair value
Locked
Current Price
$6.64
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.